MAX and lung carcinoma: Liu et al. [185] suggested that platelet mRNA groups (MAX, MTURN, and HLA-B) are associated with chemotherapy outcomes, and high expression of MAX, MTURN, and HLA-B may be linked to poor chemotherapy outcomes in lung cancer patients.